[86] claimed that RG7834, a novel oral HBV gene expression inhibitor, could decrease the amounts of viral proteins and lessen viremia. RG7834 is a small-molecule compound belonging into the dihydroquinolizinones chemical class similar to RNAi but by means of a special system. Greater danger of su